Document Detail


Comparison of Oral and Intravenous Ibuprofen for Medical Closure of Patent Ductus Arteriosus: Which One Is Better?
MedLine Citation:
PMID:  22613269     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective.  Intravenous ibuprofen is an expensive drug that is being used currently for treating and preventing patent ductus arteriosus. Although oral ibuprofen is much cheaper, there is limited data published about its safety and efficacy. The aim of this study was to compare two forms of ibuprofen in terms of safety and efficacy in closure of patent ductus arteriosus. Design.  This is a single-center retrospective study. Setting.  Data were collected from patients' files of preterm infants who were hospitalized at the Neonatal Intensive Care Unit of Dr. Behcet Uz Children's Hospital between April 2009 and June 2010. Patients.  Six hundred sixty infants were evaluated by echocardiography between 24 and 48 postnatal hours. Clinically and hemodynamically significant ductus arteriosus was defined in 66 infants with gestational age less than 32 weeks and birth weight less than 1500 g. Interventions.  Oral or intravenous ibuprofen (loading dose: 10 mg/kg on day 1, followed by maintenance dose: 5 mg/kg on days 2 and 3) was administered. Outcome Measures.  Treatment success was defined as a completely closed duct without reopening on follow-up. Drug-associated renal, gastrointestinal, cerebral, hematological, and metabolic side effects were monitored and compared between treatment groups. Results.  Ductal closure rates were 100% and 97.6%, respectively, in the oral and intravenous groups. Hypernatremia was the remarkable side effect in the intravenous group, whereas bronchopulmonary dysplasia and septicemia were prominent in the oral group. No statistically significant difference could be demonstrated between the groups in terms of mortality rates. Conclusion.  Oral ibuprofen therapy is as efficacious as intravenous ibuprofen with some concerns about increased sepsis and bronchopulmonary dysplasia incidence. However, comprehensive and large-scale pharmacokinetic studies are required in order to prove this efficacy. On the other hand, intravenous ibuprofen still remains to be the drug of choice for patent ductus arteriosus but only with meticulous control of serum sodium levels in smaller infants.
Authors:
Ozgur Olukman; Sebnem Calkavur; Gulten Ercan; Fusun Atlihan; Taliha Oner; Vedide Tavli; Nilgun Kultursay
Related Documents :
6624789 - Premature rupture of membranes: the role of c-reactive protein in the prediction of cho...
21538969 - Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (...
3195529 - Igm-enriched intravenous immunoglobulin therapy in neonatal sepsis.
16492989 - Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy.
21135279 - Analysis of the role of hematopoietic stem-cell transplantation in infants with acute l...
879839 - Bacterial colonization of infants raised in incubators and under radiant heaters.
14583909 - Elective high frequency oscillatory ventilation versus conventional ventilation for acu...
10969259 - Cerebral infarction in the term newborn: clinical presentation and long-term outcome.
1126099 - The magnesium load test: ii. correlation of clinical and laboratory data in neonates.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-22
Journal Detail:
Title:  Congenital heart disease     Volume:  -     ISSN:  1747-0803     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101256510     Medline TA:  Congenit Heart Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Wiley Periodicals, Inc.
Affiliation:
Neonatal Intensive Care Unit Department of Pediatric Cardiology, Dr. Behcet Uz Children's Hospital, Izmir, Turkey Department of Pediatrics, Division of Neonatology, Ege University Faculty of Medicine, Izmir, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear m...
Next Document:  Genetic variation for stress-response hormesis in C. elegans lifespan.